The process of hematopoietic stem cell transplantation involves the intravenous infusion of hematopoietic stem cells. The process aims to reestablish blood cell production in patients whose bone marrow or immune system is damaged or defective. Bone marrow is the soft, spongy area in the center of some of the larger bones of the body.

The global hematopoietic stem cell transplantation market is estimated to be valued at US$ 2,092.6 million in 2020 and is expected to exhibit a CAGR of 11.2% during the forecast period (2020-2027).

Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Drivers

Increasing number of hematopoietic stem cell transplants is expected to propel growth of the global hematopoietic stem cell transplantation (HSCT) market over the forecast period. For instance, the number of peripheral blood hematopoietic cell transplants (HCTs) performed in the U.S. increased from 21,487 in 2015 to 22,863 in 2017, according to the Center for International Blood and Marrow Transplant Research Transplant Activity Report.

Market Trends

Asia Pacific is expected to witness significant growth in the global hematopoietic stem cell transplantation (HSCT) market, owing to increasing number of HSCT transplants in the region. For instance, the number of transplants in Japan increased from 5468 in 2012 to 5904 in 2017, according to the Japanese Data Center for Hematopoietic Cell Transplantation.

Request Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/1250

North America accounted is also expected to witness significant growth in the global hematopoietic stem cell transplantation (HSCT) market, owing to high prevalence of leukemia. For instance, according to National Cancer Institute, the U.S. is expected to record 6,150 new cases of acute lymphocytic leukemia in 2020. ALL is highly prevalent in children between the ages of 2 and 4 years. According to Leukemia and Lymphoma Society’s 2018-2019 facts, the incidence of acute lymphoblastic leukemia was 7.8 (per 100,000) in children aged 1-4 years during 2011-2015

Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Competitive Landscape

Major players operating in the global hematopoietic stem cell transplantation (HSCT) market include, Bluebird Bio, CellGenix GmbH, Escape Therapeutics, Inc., Kiadis Pharma, Lonza Group, Marker Therapeutics Inc., Pluristem Therapeutics Inc., Regen Biopharma Inc., Stempeutics Research Pvt Ltd., Taiga Biotechnologies, Inc., Takeda Pharmaceutical Company Limited, and Talaris Therapeutics, Inc.

Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Key Developments

Major players operating in the global hematopoietic stem cell transplantation (HSCT) market are focused on R&D to expand their product portfolio. For instance, in July 2021, Vor Biopharma, a founded entity of PureTech Health plc, a clinical-stage biotherapeutics company based in the U.S., collaborated with Janssen Biotech, Inc. to develop engineered hematopoietic stem cell transplants combined with a bi-specific antibody therapy for acute myeloid leukemia.

Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Segmentation

On the basis of transplant type, the global hematopoietic stem cell transplantation (HSCT) market is segmented into:
• Allogeneic
• Autologous

On the basis of indication, the global hematopoietic stem cell transplantation (HSCT) market is segmented into:
• Acute Myeloid Leukemia (AML)
• Acute Lymphoblastic Leukemia (ALL)
• Hodgkin lymphoma (HL)
• Non-Hodgkin Lymphoma (NHL)
• Multiple Myeloma (MM)
• Other Non-malignant Disorders

On the basis of application, the global hematopoietic stem cell transplantation (HSCT) market is segmented into:
• Bone Marrow Transplant (BMT)
• Peripheral Blood Stem Cells Transplant (PBSCT)
• Cord Blood Transplant (CBT)

On the basis of region, the global hematopoietic stem cell transplantation (HSCT) market is segmented into:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Buy Now this Research Report: https://www.coherentmarketinsights.com/insight/buy-now/1250